FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Famotidine Tablets Recall

Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHAR…

Teva Pharmaceuticals USA · North Wales, PA

Risk level
Class II
Reported by FDA
Aug 9, 2017
Recall ID
D-1056-2017
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Famotidine Tablets starting Jul 24, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1056-2017 on Aug 9, 2017. Reason: Failed Tablet/Capsule Specification; out of specification for tablet weight. Status: Terminated.

Why it was recalled

Failed Tablet/Capsule Specification; out of specification for tablet weight

Product description

Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60

Lot numbers, UPCs & expiration codes

Lot # 3429066, exp 06/2018

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1056-2017
Classification
Class II
Status
Terminated
Recall initiated
Jul 24, 2017
FDA report date
Aug 9, 2017
Quantity
28,188 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA

Original FDA data

Every field from FDA enforcement report D-1056-2017, exactly as published.

Show all FDA fields
City
North Wales
State
PA
Status
Terminated
Country
United States
Event ID
77835
Address
1090 Horsham Rd
Code information
Lot # 3429066, exp 06/2018
Postal code
19454-1505
Report date
Aug 9, 2017
Product type
Drugs
Recall number
D-1056-2017
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA
Product quantity
28,188 bottles
Termination date
Jan 31, 2018
Reason for recall
Failed Tablet/Capsule Specification; out of specification for tablet weight
Voluntary / mandated
Voluntary: Firm initiated
Product description
Famotidine Tablets USP, 20 mg, 100 count bottles, Rx only, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA --- NDC 0172-5728-60
Distribution pattern
Nationwide
Recall initiation date
Jul 24, 2017
Initial firm notification
Letter
Center classification date
Aug 3, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1056-2017, published Aug 9, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls